• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy
  • Reports
    • Diabetes Technology Innovations Special Report
    • Continuous Glucose Monitoring (CGM) Market Report

Research & Development

This new nanochip technology can reprogram human cells

August 8, 2017 By Danielle Kirsh

cell conversion chip on arm

Ohio State University researchers have developed a nanochip technology that they say can create any cell type for treatment within the human body. The new technology, called Tissue Nanotransfection (TNT), can repair injured tissue and restore the function of aging tissue like organs, blood vessels and nerve cells. “By using our novel nanochip technology, injured […]

Filed Under: Featured, Research & Development Tagged With: cell conversion, medtech, The Ohio State University

Electrical fields can heal brain damage: Here’s how

August 8, 2017 By Danielle Kirsh

brain scan

Electrical fields can guide neural stem cells into a specific location to repair brain damage, according to new research from the University of California at Davis. Min Zhao, a researcher at UC Davis, studies how electric fields can guide wound healing. His previous research has shown that electric fields are able to attract cells into […]

Filed Under: Featured, Neurological, Research & Development Tagged With: medtech, University of California at Davis

How slugs are creating better medical adhesives

August 4, 2017 By Danielle Kirsh

Slug mucus is the inspiration behind a new adhesive to close surgical wounds and reduce the use of surgical staples, according to new research out of Harvard. Some of the current adhesives on the market can be toxic and stick together tissues weakly. Some can’t be used in wet environments altogether, which can pose a […]

Filed Under: Research & Development, Surgical, Wound Care Tagged With: hemostat, medtech, surgical adhesive

Study: Injectable antiretroviral therapy proves as effective as oral treatment

August 4, 2017 By Sarah Faulkner

Injectable antiretroviral therapy may be as effective as standard oral treatment in patients with HIV, according to the results of a Phase II clinical trial. The 286-patient study, published in The Lancet, compared a nanoparticle therapy that was injected intramuscularly every four or eight weeks with standard maintenance therapy. “This is the first time that all-injectable […]

Filed Under: Clinical Trials, Drug-Device Combinations, Featured, Nanoparticles, Pharmaceuticals, Research & Development

Researchers develop stem cell therapy to fight inflammatory lung conditions

August 4, 2017 By Sarah Faulkner

Researchers from the UNC School of Medicine and North Carolina State University showed that they could harvest and multiply lung stem cells in volumes sufficient for human therapy.  In a second study, the team used their cell therapy to treat a model of idiopathic pulmonary fibrosis. The scientists reported that they are in talks with […]

Filed Under: Featured, Pharmaceuticals, Regenerative Medicine, Research & Development, Stem Cells

This tiny diaphragm pump could enable medical device innovation

August 3, 2017 By Danielle Kirsh

smartpump

Fraunhofer researchers have created a tiny yet powerful diaphragm pump that can deliver ambient air to gas sensors. The sensors are attached to a smartphone that warns a user of heavy exposure to particulate matter. “Our smart pump measures only 25 sq mm, making it the world’s smallest pump. That said, it still has a […]

Filed Under: Research & Development Tagged With: fraunhofer, medtech

ViaCyte launches cell replacement trial for Type I diabetes

August 1, 2017 By Sarah Faulkner

ViaCyte

Regenerative medicine company ViaCyte said today that the first patients have been implanted in a trial of its islet cell replacement therapy, PEC-Direct. San Diego-based ViaCyte is developing the cell therapy as a functional cure for patients with Type I diabetes who are at risk of suffering acute life-threatening complications. The company’s open-label clinical trial […]

Filed Under: Clinical Trials, Diabetes, Drug-Device Combinations, Featured, Research & Development, Stem Cells Tagged With: Juvenile Diabetes Research Foundation (JDRF), ViaCyte

Boston Scientific to end Renuvia bioresorbable coronary stent program

July 31, 2017 By Fink Densford

Boston Scientific

Boston Scientific (NYSE:BSX) is looking to terminate its Renuvia bioresorbable coronary stent program, according to a Minneapolis Star Tribune report. The move comes after new clinical studies of Abbott‘s (NYSE:ABT) Absorb bioresorbable stent indicated that use of the device resulted in a higher risk of serious adverse events compared to metal stents. Marlborough, Mass.-based Boston Scientific said that while the […]

Filed Under: Business/Financial News, Cardiovascular, Featured, Research & Development, Stents, Vascular Tagged With: abbott, Boston Scientific

Aerie inks deal for implantable drug-delivery system

July 31, 2017 By Sarah Faulkner

Aerie

Aerie Pharmaceuticals (NSDQ:AERI) said today that it inked a collaborative R&D and licensing agreement with DSM to develop an implantable drug-delivery system for patients with glaucoma and other retinal diseases. DSM has reportedly developed an injectable drug-delivery fiber using polyesteramide polymers that has proven successful in preclinical work with Aerie’s compounds. A product candidate developed by […]

Filed Under: Drug-Device Combinations, Featured, Optical/Ophthalmic, Pharmaceuticals, Research & Development, Wall Street Beat Tagged With: Aerie Pharmaceuticals, DSM

Icon beats Street on Q2 earnings, acquires Mapi Group

July 27, 2017 By Chris Newmarker

Icon PLC

Drug development provider Icon PLC (Nasdaq: ICLR) saw its stock jump about 6% in value today after announcing second-quarter earnings that beat analysts’ expectations. The Dublin, Ireland–based company, which serves the pharmaceutical, biotechnology and medical device industries, also said it has acquired the Mapi Group, which provides patient-centered health outcomes research and commercialisation. Financial terms of […]

Filed Under: Business/Financial News, Clinical Trials, Contract Services, Drug-Device Combinations, Featured, Mergers & Acquisitions, Pharmaceuticals, Preclinical Trials, Regulatory/Compliance, Research & Development, Wall Street Beat Tagged With: iconplc

  • « Go to Previous Page
  • Page 1
  • Interim pages omitted …
  • Page 19
  • Page 20
  • Page 21
  • Page 22
  • Page 23
  • Interim pages omitted …
  • Page 48
  • Go to Next Page »

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.
MDO

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
About
Contact us
Listen to our Weekly Podcasts
Advertise

Copyright © 2026 · Arrowfly LLC. All Rights Reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy | Terms & Conditions | RSS